Literature DB >> 25111073

Mutational landscape of candidate genes in familial prostate cancer.

Anna M Johnson1, Kimberly A Zuhlke, Chris Plotts, Shannon K McDonnell, Sumit Middha, Shaun M Riska, Daniel J Schaid, Stephen N Thibodeau, Julie A Douglas, Kathleen A Cooney.   

Abstract

BACKGROUND: Family history is a major risk factor for prostate cancer (PCa), suggesting a genetic component to the disease. However, traditional linkage and association studies have failed to fully elucidate the underlying genetic basis of familial PCa.
METHODS: Here, we use a candidate gene approach to identify potential PCa susceptibility variants in whole exome sequencing data from familial PCa cases. Six hundred ninety-seven candidate genes were identified based on function, location near a known chromosome 17 linkage signal, and/or previous association with prostate or other cancers. Single nucleotide variants (SNVs) in these candidate genes were identified in whole exome sequence data from 33 PCa cases from 11 multiplex PCa families (3 cases/family).
RESULTS: Overall, 4,856 candidate gene SNVs were identified, including 1,052 missense and 10 nonsense variants. Twenty missense variants were shared by all three family members in each family in which they were observed. Additionally, 15 missense variants were shared by two of three family members and predicted to be deleterious by five different algorithms. Four missense variants, BLM Gln123Arg, PARP2 Arg283Gln, LRCC46 Ala295Thr and KIF2B Pro91Leu, and one nonsense variant, CYP3A43 Arg441Ter, showed complete co-segregation with PCa status. Twelve additional variants displayed partial co-segregation with PCa.
CONCLUSIONS: Forty-three nonsense and shared, missense variants were identified in our candidate genes. Further research is needed to determine the contribution of these variants to PCa susceptibility.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  exome sequencing; familial cancer; susceptibility

Mesh:

Substances:

Year:  2014        PMID: 25111073      PMCID: PMC4142071          DOI: 10.1002/pros.22849

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  38 in total

1.  Syndrome-causing mutations of the BLM gene in persons in the Bloom's Syndrome Registry.

Authors:  James German; Maureen M Sanz; Susan Ciocci; Tian Z Ye; Nathan A Ellis
Journal:  Hum Mutat       Date:  2007-08       Impact factor: 4.878

Review 2.  Genetic etiology of hereditary prostate cancer.

Authors:  Wendy J Langeberg; William B Isaacs; Janet L Stanford
Journal:  Front Biosci       Date:  2007-05-01

3.  The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.

Authors:  J P Struewing; P Hartge; S Wacholder; S M Baker; M Berlin; M McAdams; M M Timmerman; L C Brody; M A Tucker
Journal:  N Engl J Med       Date:  1997-05-15       Impact factor: 91.245

4.  CYP3A43 Pro(340)Ala polymorphism and prostate cancer risk in African Americans and Caucasians.

Authors:  Angie Stone; Luke D Ratnasinghe; Ginny L Emerson; Rama Modali; Terri Lehman; Gail Runnells; Alindria Carroll; Weleetka Carter; Samuel Barnhart; Al A Rasheed; Graham Greene; Don E Johnson; Christine B Ambrosone; Fred F Kadlubar; Nicholas P Lang
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-05       Impact factor: 4.254

5.  A combined genomewide linkage scan of 1,233 families for prostate cancer-susceptibility genes conducted by the international consortium for prostate cancer genetics.

Authors:  Jianfeng Xu; Latchezar Dimitrov; Bao-Li Chang; Tamara S Adams; Aubrey R Turner; Deborah A Meyers; Rosalind A Eeles; Douglas F Easton; William D Foulkes; Jacques Simard; Graham G Giles; John L Hopper; Lovise Mahle; Pal Moller; Tim Bishop; Chris Evans; Steve Edwards; Julia Meitz; Sarah Bullock; Questa Hope; Chih-Lin Hsieh; Jerry Halpern; Raymond N Balise; Ingrid Oakley-Girvan; Alice S Whittemore; Charles M Ewing; Marta Gielzak; Sarah D Isaacs; Patrick C Walsh; Kathleen E Wiley; William B Isaacs; Stephen N Thibodeau; Shannon K McDonnell; Julie M Cunningham; Katherine E Zarfas; Scott Hebbring; Daniel J Schaid; Danielle M Friedrichsen; Kerry Deutsch; Suzanne Kolb; Michael Badzioch; Gail P Jarvik; Marta Janer; Leroy Hood; Elaine A Ostrander; Janet L Stanford; Ethan M Lange; Jennifer L Beebe-Dimmer; Caroline E Mohai; Kathleen A Cooney; Tarja Ikonen; Agnes Baffoe-Bonnie; Henna Fredriksson; Mika P Matikainen; Teuvo Lj Tammela; Joan Bailey-Wilson; Johanna Schleutker; Christiane Maier; Kathleen Herkommer; Josef J Hoegel; Walther Vogel; Thomas Paiss; Fredrik Wiklund; Monica Emanuelsson; Elisabeth Stenman; Bjorn-Anders Jonsson; Henrik Gronberg; Nicola J Camp; James Farnham; Lisa A Cannon-Albright; Daniela Seminara
Journal:  Am J Hum Genet       Date:  2005-06-29       Impact factor: 11.025

6.  Fine-mapping the putative chromosome 17q21-22 prostate cancer susceptibility gene to a 10 cM region based on linkage analysis.

Authors:  Ethan M Lange; Christiane M Robbins; Elizabeth M Gillanders; Siqun Lilly Zheng; Jianfeng Xu; Yunfei Wang; Kirsten A White; Bao-Li Chang; Lindsey A Ho; Jeffrey M Trent; John D Carpten; William B Isaacs; Kathleen A Cooney
Journal:  Hum Genet       Date:  2006-11-21       Impact factor: 4.132

7.  Germline mutations in the BRCA2 gene and susceptibility to hereditary prostate cancer.

Authors:  Ilir Agalliu; Erika M Kwon; Daniel Zadory; Laura McIntosh; Joseph Thompson; Janet L Stanford; Elaine A Ostrander
Journal:  Clin Cancer Res       Date:  2007-02-01       Impact factor: 12.531

8.  Bloom syndrome: an analysis of consanguineous families assigns the locus mutated to chromosome band 15q26.1.

Authors:  J German; A M Roe; M F Leppert; N A Ellis
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-05       Impact factor: 11.205

9.  Genetic polymorphisms in DNA base-excision repair genes ADPRT, XRCC1, and APE1 and the risk of squamous cell carcinoma of the head and neck.

Authors:  Chunying Li; Zhibin Hu; Jiachun Lu; Zhensheng Liu; Li-E Wang; Adel K El-Naggar; Erich M Sturgis; Margaret R Spitz; Qingyi Wei
Journal:  Cancer       Date:  2007-08-15       Impact factor: 6.860

10.  Common variation in the BRCA1 gene and prostate cancer risk.

Authors:  Julie A Douglas; Albert M Levin; Kimberly A Zuhlke; Anna M Ray; Gregory R Johnson; Ethan M Lange; David P Wood; Kathleen A Cooney
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-06-21       Impact factor: 4.254

View more
  11 in total

1.  Rare Variation in TET2 Is Associated with Clinically Relevant Prostate Carcinoma in African Americans.

Authors:  Daniel C Koboldt; Krishna L Kanchi; Bin Gui; David E Larson; Robert S Fulton; William B Isaacs; Aldi Kraja; Ingrid B Borecki; Li Jia; Richard K Wilson; Elaine R Mardis; Adam S Kibel
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-08-02       Impact factor: 4.254

2.  Germline BLM mutations and metastatic prostate cancer.

Authors:  Elisa M Ledet; Emmanuel S Antonarakis; William B Isaacs; Tamara L Lotan; Colin Pritchard; A Oliver Sartor
Journal:  Prostate       Date:  2019-11-05       Impact factor: 4.104

Review 3.  Understanding specific functions of PARP-2: new lessons for cancer therapy.

Authors:  Syed O Ali; Farhaan A Khan; Miguel A Galindo-Campos; José Yélamos
Journal:  Am J Cancer Res       Date:  2016-09-01       Impact factor: 6.166

4.  Association between polymorphisms in TP53 and MDM2 genes and susceptibility to prostate cancer.

Authors:  Mohammad Hashemi; Shadi Amininia; Mahboubeh Ebrahimi; Nasser Simforoosh; Abbas Basiri; Seyed Amir Mohsen Ziaee; Behzad Narouie; Mehdi Sotoudeh; Mohammad Javad Mollakouchekian; Esmaeil Rezghi Maleki; Hamideh Hanafi-Bojd; Maryam Rezaei; Gholamreza Bahari; Mohsen Taheri; Saeid Ghavami
Journal:  Oncol Lett       Date:  2017-02-14       Impact factor: 2.967

Review 5.  A Systematic Literature Review of Whole Exome and Genome Sequencing Population Studies of Genetic Susceptibility to Cancer.

Authors:  Alisa M Goldstein; Elizabeth M Gillanders; Melissa Rotunno; Rolando Barajas; Mindy Clyne; Elise Hoover; Naoko I Simonds; Tram Kim Lam; Leah E Mechanic
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-05-28       Impact factor: 4.254

6.  New insights into the genetics of glioblastoma multiforme by familial exome sequencing.

Authors:  Christina Backes; Christian Harz; Ulrike Fischer; Jana Schmitt; Nicole Ludwig; Britt-Sabina Petersen; Sabine C Mueller; Yoo-Jin Kim; Nadine M Wolf; Hugo A Katus; Benjamin Meder; Rhoikos Furtwängler; Andre Franke; Rainer Bohle; Wolfram Henn; Norbert Graf; Andreas Keller; Eckart Meese
Journal:  Oncotarget       Date:  2015-03-20

Review 7.  Advances in genetics: widening our understanding of prostate cancer.

Authors:  Angela C Pine; Flavia F Fioretti; Greg N Brooke; Charlotte L Bevan
Journal:  F1000Res       Date:  2016-06-27

8.  Whole exome sequencing in 75 high-risk families with validation and replication in independent case-control studies identifies TANGO2, OR5H14, and CHAD as new prostate cancer susceptibility genes.

Authors:  Danielle M Karyadi; Milan S Geybels; Eric Karlins; Brennan Decker; Laura McIntosh; Amy Hutchinson; Suzanne Kolb; Shannon K McDonnell; Belynda Hicks; Sumit Middha; Liesel M FitzGerald; Melissa S DeRycke; Meredith Yeager; Daniel J Schaid; Stephen J Chanock; Stephen N Thibodeau; Sonja I Berndt; Janet L Stanford; Elaine A Ostrander
Journal:  Oncotarget       Date:  2017-01-03

9.  RecQ helicase BLM regulates prostate cancer cell proliferation and apoptosis.

Authors:  Xiaosong Qian; Sujuan Feng; Dawei Xie; Dalin Feng; Yihang Jiang; Xiaodong Zhang
Journal:  Oncol Lett       Date:  2017-08-02       Impact factor: 2.967

Review 10.  Exploring the Role of Fallopian Ciliated Cells in the Pathogenesis of High-Grade Serous Ovarian Cancer.

Authors:  Michela Coan; Gian Luca Rampioni Vinciguerra; Laura Cesaratto; Emanuela Gardenal; Riccardo Bianchet; Erik Dassi; Andrea Vecchione; Gustavo Baldassarre; Riccardo Spizzo; Milena Sabrina Nicoloso
Journal:  Int J Mol Sci       Date:  2018-08-24       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.